Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric antigen receptor (CAR) T cells have shown unparalleled therapeutic potential in treating refractory hematological malignanci...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoiber, Stefan, Cadilha, Bruno L., Benmebarek, Mohamed-Reda, Lesch, Stefanie, Endres, Stefan, Kobold, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562702/
https://www.ncbi.nlm.nih.gov/pubmed/31108883
http://dx.doi.org/10.3390/cells8050472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562702/
https://www.ncbi.nlm.nih.gov/pubmed/31108883
http://dx.doi.org/10.3390/cells8050472

Ejemplares similares